Comprehensive Genomic Profiling

The AJMC® Comprehensive Genomic Profiling compendium is a comprehensive resource for clinical news and expert insights for the next-generation sequencing approach to assess genes for the purpose of therapy guidance.

Contributor: The Convergence of Value-Based Care and Lab Testing Growth

May 17th 2022, 5:15pm


Today, health plans are shifting dollars to more value-based contracts along with investments in population health management. Digitizing lab results across all care settings and unlocking the potential of lab values can help health plans reach the Triple Aim of improving the patient experience, improving the health of populations, and reducing the per-member cost of health care.

Dr Patricia Deverka Explains Next Steps Toward Medicare Coverage of Multicancer Early Detection Tests

May 13th 2022, 7:15pm


The US Preventive Services Task Force has never evaluated a multicancer screening test for endorsement, which may make the process even longer, said Patricia Deverka, MD, MS, senior researcher, deputy director at the Center for Translational and Policy Research and Precision Medicine, University of California San Francisco.

Assessing Cost Savings, Waste Reduction From Pharmacogenomics and Precision Medicine

May 11th 2022, 8:47pm


David Skomo, and Nick Page, PharmD, of WellDyne offered their perspectives on recent developments in precision medicine at the 2022 Asembia Specialty Pharmacy Summit.

Next-Generation Sequencing Finds Different Molecular Profiles of Pediatric, Adult Sarcomas

May 7th 2022, 5:20pm


Next-generation sequencing identified different molecular profiles of pediatric and adult sarcomas among Chinese patients.

Dr Sneha Sharma Discusses the Growing Roles of Biomarker Testing, Biosimilars

May 5th 2022, 12:28pm


Biomarker testing is having growing importance to ensure that patients are started on the correct therapy for the best outcomes, said Sneha Sharma, PharmD, director, specialty clinical solutions, Magellan Rx.

Dr Patricia Deverka Discusses Access, Research for Multicancer Early Detection Tests

April 29th 2022, 5:37pm


Patricia Deverka, MD, MS, senior researcher, deputy director at the Center for Translational and Policy Research and Precision Medicine, University of California San Francisco, explains what multicancer early detection tests currently exist and the research needed to understand their clinical utility.

Contributor: Top 3 Future Therapies to Drive Hemophilia Treatment Market Growth

April 24th 2022, 11:32am


The trends in the hemophilia treatment market are gaining momentum with increasing incidences of hemophilia A and B and staggering need for their treatments, including gene, anti-tissue factor pathway inhibitor, and factor replacement therapies.

NPC's Michael Ciarametaro on How Clinics Can Surmount Gene Therapy Data Collection Barriers

April 22nd 2022, 6:35pm


Michael Ciarametaro, MBA, vice president of research at the National Pharmaceutical Council, highlights steps clinics can take to mitigate issues related to data collection regarding cell and gene therapies.

Spotlighting Health-, Cost-Related Benefits of Genomic Testing and How Employers Can Drive Adoption

April 20th 2022, 12:20pm


Key opinion leaders addressed cost, accessibility, and other barriers limiting use of comprehensive genomic profiling (CGP), and how employers can help drive preventive care and precision medicine through CGP.

Expert: Better Harmony Is Needed to Prevent Compromised Specimens During CGP Testing

April 15th 2022, 6:12pm


Despite technological advancements, there are still many factors that can cause specimens for comprehensive genomic profiling (CGP) testing to become compromised, potentially leading to inaccurate prognostic results, according to a recent webinar.